Abstract
A summary of the pathophysiology and clinical use of the argon laser in the treatment of cutaneous lesions is presented. The nonionizing blue-green argon laser light is absorbed by pigment, is converted to heat, and selectively destroys specific cutaneous lesions with sparing of adjacent dermal appendages and healing of the laser wound with minimal scarring. Vascular lesions (port wine hemangioma, capillary-cavernous hemangioma, telangiectasia), inflammatory lesions (pyogenic granuloma), nevoid lesions, tattoo lesions, and a variety of miscellaneous lesions have been successfully treated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
